Diet-induced Fasting Ghrelin Elevation Reflects the Recovery of Insulin Sensitivity and Visceral Adiposity Regression
- PMID: 34643713
- DOI: 10.1210/clinem/dgab681
Diet-induced Fasting Ghrelin Elevation Reflects the Recovery of Insulin Sensitivity and Visceral Adiposity Regression
Abstract
Context: Lower fasting ghrelin levels (FGL) are associated with obesity and metabolic syndrome.
Objective: We aimed to explore the dynamics of FGL during weight loss and its metabolic and adiposity-related manifestations beyond weight loss.
Methods: This was a secondary analysis of a clinical trial that randomized participants with abdominal obesity/dyslipidemia to 1 of 3 diets: healthy dietary guidelines (HDG), Mediterranean diet (MED), or green-MED diet, all combined with physical activity (PA). Both MED diets were similarly hypocaloric and included 28 g/day walnuts. The green-MED group further consumed green tea (3-4 cups/day) and a Wolffia globosa (Mankai) plant green shake. We measured FGL and quantified body fat depots by magnetic resonance imaging at baseline and after 18 months.
Results: Among 294 participants (body mass index = 31.3 kg/m2; FGL = 504 ± 208 pg/mL; retention rate = 89.8%), lower FGL was associated with unfavorable cardiometabolic parameters such as higher visceral adipose tissue (VAT), intrahepatic fat, leptin, and blood pressure (P < 0.05 for all; multivariate models). The ∆FGL18-month differed between men (+7.3 ± 26.6%) and women (-9.2% ± 21.3%; P = 0.001). After 18 months of moderate and similar weight loss among the MED groups, FGL increased by 1.3%, 5.4%, and 10.5% in HDG, MED, and green-MED groups, respectively (P = 0.03 for green-MED vs HDG); sex-stratified analysis revealed similar changes in men only. Among men, FGL18-month elevation was associated with favorable changes in insulin resistance profile and VAT regression, after adjusting for relative weight loss (HbA1c: r = -0.216; homeostatic model of insulin resistance: r = -0.154; HDL-c: r = 0.147; VAT: r = -0.221; P < 0.05 for all). Insulin resistance and VAT remained inversely related with FGL elevation beyond that explained by weight loss (residual regression analyses; P < 0.05).
Conclusion: Diet-induced FGL elevation may reflect insulin sensitivity recovery and VAT regression beyond weight loss, specifically among men. Green-MED diet is associated with greater FGL elevation.
Trial registration: ClinicalTrials.gov NCT03020186.
Keywords: fasting ghrelin; insulin resistance; lifestyle intervention; metabolic syndrome; weight loss.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial.Circulation. 2018 Mar 13;137(11):1143-1157. doi: 10.1161/CIRCULATIONAHA.117.030501. Epub 2017 Nov 15. Circulation. 2018. PMID: 29142011 Clinical Trial.
-
The effect of high-polyphenol Mediterranean diet on visceral adiposity: the DIRECT PLUS randomized controlled trial.BMC Med. 2022 Sep 30;20(1):327. doi: 10.1186/s12916-022-02525-8. BMC Med. 2022. PMID: 36175997 Free PMC article. Clinical Trial.
-
Long-term green-Mediterranean diet may favor fasting morning cortisol stress hormone; the DIRECT-PLUS clinical trial.Front Endocrinol (Lausanne). 2023 Nov 14;14:1243910. doi: 10.3389/fendo.2023.1243910. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034010 Free PMC article. Clinical Trial.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Perceived stress correlates with visceral obesity and lipid parameters of the metabolic syndrome: A systematic review and meta-analysis.Psychoneuroendocrinology. 2018 Sep;95:63-73. doi: 10.1016/j.psyneuen.2018.05.014. Epub 2018 May 12. Psychoneuroendocrinology. 2018. PMID: 29803182 Review.
Cited by
-
Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery.Obes Surg. 2023 Dec;33(12):3988-3998. doi: 10.1007/s11695-023-06905-8. Epub 2023 Nov 1. Obes Surg. 2023. PMID: 37910328 Free PMC article.
-
Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional Study.Healthcare (Basel). 2023 Oct 9;11(19):2696. doi: 10.3390/healthcare11192696. Healthcare (Basel). 2023. PMID: 37830733 Free PMC article.
-
Sex-specific differences in metabolic hormone and adipose tissue dynamics induced by moderate low-carbohydrate and ketogenic diet.Sci Rep. 2023 Sep 30;13(1):16465. doi: 10.1038/s41598-023-43587-9. Sci Rep. 2023. PMID: 37777528 Free PMC article.
-
Cardiovascular Disease Risk Reduction and Body Mass Index.Curr Hypertens Rep. 2022 Nov;24(11):535-546. doi: 10.1007/s11906-022-01213-5. Epub 2022 Jul 5. Curr Hypertens Rep. 2022. PMID: 35788967 Review.
